Kevin Rakin, Director at HISTOGENICS CORP (HSGX), sold 75 shares at $11.00 ($187) on 2014-12-08, disclosed to the SEC on 2014-12-08.
Open-market sale of $187 HSGX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 58 | $0 | 0.0% |
| 2 | $11.00 | 17 | $187 | 100.0% |
| Total | $2.49 avg | 75 | $187 | 100% |
| Filing → |
| ORMP | SELL | 2022-03-22 | $94K | — | Filing → |
| ORMP | SELL | 2021-09-20 | $886K | — | Filing → |
| OMRI | BUY | 2008-03-28 | $27K | — | Filing → |